download.png

PharmEasy (API Holdings Pvt. Ltd) Unlisted Shares

Pre-IPO 
Company

About Company:

Launched in 2015, PharmEasy was started with the sole purpose of making healthcare accessible and affordable to all, PharmEasy today is India’s leading and most trusted online healthcare aggregator in the country. They help patients connect with local pharmacy stores and diagnostic centers to fulfill their extensive medical needs. Today, PharmEasy delivers medicines in 1000+ cities in India.

Company Overview

PharmEasy is India’s leading digital healthcare platform. It provides information, consultations, diagnostics tests, medicines, healthcare products and services from registered and trusted pharmacies, leading diagnostic laboratories and trusted doctors across India, serving every habitable zip code of the country.


They are India’s largest digital healthcare platform (based on GMV of products and services sold for the year ended March 31, 2021), according to RedSeer Report.


They operate an integrated, end-to-end business that aims to provide solutions for healthcare needs of consumers across the following critical stages:

  • providing digital tools and information on illness and wellness.

  • offering Teleconsultation.

  • offering diagnostics and Radiology tests.

  • delivering treatment protocols including products and devices.


PharmEasy custom-built proprietary technology, unified data platforms, supply chain capabilities, and deep understanding of the dynamic interplay between the various sub-segments of India’s healthcare market are the capabilities that differentiate us.

Promoter-Management

Name Designation

Siddharth Shah CEO & Co-Founder

Dr. Dhaval Shah Co-founder

Aditya Puri Chairman and Non-Executive Director Harsh Parekh Co-founder and Whole-time Director

Dharmil Sheth Co-Founder and Whole-time Director

Shareholders Pattern

Name % of Total Shares

Other Investors 63.73%

Naspers Ventures BV 12.04%

Macritchie Investments Pte. Ltd 10.84%

Surbhi Singh & Universal Trustees Pvt. Ltd. 6.70%

TP G Growth V SF Markets Pte. Ltd. 6.65%

Annual Reports


90a77-api-group-corporation-2019-annual-report
.pdf
Download PDF • 2.82MB

5a2f9-api-group-2020-annual-report
.pdf
Download PDF • 14.01MB

Investing Opportunities

The businesses have a presence across the country, with last-mile 163 capabilities to deliver in over 18,587 pin codes (for June 2021) via PharmEasy marketplace, allowing the ability to provide access in an affordable manner to the common man. 


The platforms have scaled across urban, semi-urban and rural India, with an ability to serve people across income groups and geographies.


Currently, there is a team of 4000+ dedicated employees and have more than 10000+ retail stores working 24*7 to ensure medicines are delivered on time and at the best possible prices.


PharmEasy has access to capital more than other players in the space because they grew revenues fast, but the true test of the business will be if it can generate profits in the next few years and reinvest it in growth. But having a pharma distribution supply chain does help them integrate the product better

Frequently Asked Questions